We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
-7.37%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$65.6B
AUM Growth
-$4.01B
Cap. Flow
+$2.13B
Cap. Flow %
3.25%
Top 10 Hldgs %
17.81%
Holding
764
New
62
Increased
390
Reduced
214
Closed
64

Top Sells

Rank Stock Value
1
OCR
OMNICARE INC
OCR
+$369M
2
EMC
EMC CORPORATION
EMC
+$356M
3
ALL icon
Allstate
ALL
+$332M
4
CVS icon
CVS Health
CVS
+$325M
5
TEL icon
TE Connectivity
TEL
+$268M

Sector Composition

Rank Sector Weight
1 Financials 26.35%
2 Healthcare 15.13%
3 Technology 14.24%
4 Industrials 12.69%
5 Consumer Discretionary 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TT icon
51
Trane Technologies
TT
$106B
$343M 0.52%
6,749,349
+1,115,497
+20% +$66.7M
GD icon
52
General Dynamics
GD
$105B
$339M 0.52%
2,453,943
+457,014
+23% +$66.1M
NXPI icon
53
NXP Semiconductors
NXPI
$68B
$335M 0.51%
3,850,326
-198,779
-5% -$17.9M
M icon
54
Macy's
M
$6.15B
$335M 0.51%
6,526,173
-1,768,726
-21% -$111M
RHI icon
55
Robert Half
RHI
$3.61B
$326M 0.5%
6,363,042
+611,282
+11% +$32.9M
RJF icon
56
Raymond James Financial
RJF
$32.5B
$325M 0.5%
9,829,164
+657,720
+7% +$24.4M
MET icon
57
MetLife
MET
$61B
$324M 0.49%
7,708,005
+1,604,548
+26% +$75M
ALL icon
58
Allstate
ALL
$66.9B
$315M 0.48%
5,400,587
-5,306,250
-50% -$332M
NWL icon
59
Newell Brands
NWL
$2.16B
$307M 0.47%
7,730,291
+669,289
+9% +$28.1M
TRV icon
60
Travelers Companies
TRV
$80.8B
$305M 0.47%
3,064,935
-653,783
-18% -$66.9M
FIS icon
61
Fidelity National Information Services
FIS
$21.5B
$303M 0.46%
4,510,129
+189,645
+4% +$12.6M
AVY icon
62
Avery Dennison
AVY
$12.3B
$301M 0.46%
5,326,223
+315,956
+6% +$19.1M
AMTD
63
DELISTED
TD Ameritrade Holding Corp
AMTD
$297M 0.45%
9,338,016
+878,392
+10% +$30.8M
ELV icon
64
Elevance Health
ELV
$81.9B
$288M 0.44%
2,058,177
-437,379
-18% -$65.7M
EBAY icon
65
eBay
EBAY
$48.6B
$284M 0.43%
11,624,283
+6,588,976
+131% +$177M
TEVA icon
66
Teva Pharmaceuticals
TEVA
$35.9B
$282M 0.43%
5,003,291
-3,752,147
-43% -$243M
MAN icon
67
ManpowerGroup
MAN
$2.39B
$279M 0.43%
3,409,265
+238,516
+8% +$21.2M
EFX icon
68
Equifax
EFX
$20.3B
$277M 0.42%
2,853,969
-185,340
-6% -$18.4M
CI icon
69
Cigna
CI
$76.6B
$275M 0.42%
2,039,060
+240,217
+13% +$34.9M
WRK
70
DELISTED
WestRock Company
WRK
$270M 0.41%
+5,830,276
New +$312M
HOG icon
71
Harley-Davidson
HOG
$2.68B
$267M 0.41%
4,870,590
+2,977,673
+157% +$168M
SWK icon
72
Stanley Black & Decker
SWK
$14.2B
$266M 0.4%
2,738,046
+990,631
+57% +$102M
BXP icon
73
Boston Properties
BXP
$11B
$265M 0.4%
2,240,282
+200,904
+10% +$24M
JBL icon
74
Jabil
JBL
$32.8B
$263M 0.4%
11,760,484
+1,564,563
+15% +$31.1M
EXPE icon
75
Expedia Group
EXPE
$31.2B
$258M 0.39%
2,191,579
+252,197
+13% +$29.1M

Similar funds

Boston Partners's Q3 2015 Portfolio in Review

As of Q3 2015, Boston Partners held 764 positions worth $65.6B, down 5.8% from $69.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Partners deployed $2.13B of net new capital in Q3 2015, opening 62 new positions and adding to 390 existing holdings. Its largest new stake was WestRock Company: 5,830,276 shares worth $270M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was EMC CORPORATION, an estimated $356M trimmed.

  • Boston Partners's largest Q3 2015 buy was WestRock Company: 5,830,276 shares worth $270M.
  • Boston Partners added most to Johnson & Johnson in Q3 2015, an estimated $282M increase.
  • Boston Partners's biggest Q3 2015 reduction was EMC CORPORATION, cutting an estimated $356M.
  • Boston Partners fully exited OMNICARE INC in Q3 2015, selling an estimated $369M.
  • Boston Partners's ten largest holdings make up 18% of its $65.6B portfolio in Q3 2015.
  • Boston Partners opened 62 new positions and closed 64 in Q3 2015.
  • Boston Partners's portfolio value fell 5.8% quarter-over-quarter to $65.6B.

Based on Boston Partners's 13F filing for Q3 2015, filed 10 Nov 2015.